Porvair plc (LON:PRV – Get Free Report) insider Hooman Caman Javvi acquired 5,701 shares of the stock in a transaction dated Monday, February 9th. The shares were bought at an average cost of GBX 870 per share, with a total value of £49,598.70.
Porvair Stock Down 1.2%
Shares of LON:PRV opened at GBX 856 on Wednesday. The firm’s 50 day moving average price is GBX 843.54 and its 200 day moving average price is GBX 782.11. The stock has a market cap of £394.92 million, a price-to-earnings ratio of 23.32 and a beta of 0.76. Porvair plc has a fifty-two week low of GBX 624.70 and a fifty-two week high of GBX 920. The company has a quick ratio of 1.22, a current ratio of 1.83 and a debt-to-equity ratio of 19.67.
Porvair (LON:PRV – Get Free Report) last posted its quarterly earnings results on Monday, February 9th. The company reported GBX 42.30 EPS for the quarter. Porvair had a net margin of 8.57% and a return on equity of 10.75%. As a group, equities research analysts predict that Porvair plc will post 39.0358613 earnings per share for the current fiscal year.
Analyst Ratings Changes
Get Our Latest Analysis on PRV
About Porvair
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.
Read More
- Five stocks we like better than Porvair
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.
